BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 18599616)

  • 1. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus.
    Jin T; Liu L
    Mol Endocrinol; 2008 Nov; 22(11):2383-92. PubMed ID: 18599616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCF7L2 and type 2 diabetes--we WNT to know.
    Smith U
    Diabetologia; 2007 Jan; 50(1):5-7. PubMed ID: 17102948
    [No Abstract]   [Full Text] [Related]  

  • 3. Wnt signaling in pancreatic islets.
    Liu Z; Habener JF
    Adv Exp Med Biol; 2010; 654():391-419. PubMed ID: 20217507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCF7L2 genetic defect and type 2 diabetes.
    Cauchi S; Froguel P
    Curr Diab Rep; 2008 Apr; 8(2):149-55. PubMed ID: 18445358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross talk between the insulin and Wnt signaling pathways: evidence from intestinal endocrine L cells.
    Yi F; Sun J; Lim GE; Fantus IG; Brubaker PL; Jin T
    Endocrinology; 2008 May; 149(5):2341-51. PubMed ID: 18258680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants and haplotypes of TCF7L2 are associated with β-cell function in patients with newly diagnosed type 2 diabetes: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 1.
    Bonetti S; Trombetta M; Malerba G; Boselli L; Trabetti E; Muggeo M; Stoico V; Negri C; Pignatti PF; Bonora E; Bonadonna RC
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E389-93. PubMed ID: 21159844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin treatment and high-fat diet feeding reduces the expression of three Tcf genes in rodent pancreas.
    Columbus J; Chiang Y; Shao W; Zhang N; Wang D; Gaisano HY; Wang Q; Irwin DM; Jin T
    J Endocrinol; 2010 Oct; 207(1):77-86. PubMed ID: 20675304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Wnt signaling in the development of type 2 diabetes.
    Bordonaro M
    Vitam Horm; 2009; 80():563-81. PubMed ID: 19251050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt signaling: relevance to beta-cell biology and diabetes.
    Welters HJ; Kulkarni RN
    Trends Endocrinol Metab; 2008 Dec; 19(10):349-55. PubMed ID: 18926717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys.
    Marzi C; Huth C; Kolz M; Grallert H; Meisinger C; Wichmann HE; Rathmann W; Herder C; Illig T
    Horm Metab Res; 2007 Jan; 39(1):46-52. PubMed ID: 17226113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of LRP5, TCF7L2, and GCG variants and type 2 diabetes mellitus as well as fasting plasma glucose and lipid metabolism indexes.
    Wang J; Yan G; Zhang J; Gao K; Zhang M; Li L; Wang Y; Wang Q; Zhai Y; You H; Ren Y; Wang B; Hu D
    Hum Immunol; 2015 May; 76(5):339-43. PubMed ID: 25863010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes susceptibility gene TCF7L2 and its role in beta-cell function.
    Gloyn AL; Braun M; Rorsman P
    Diabetes; 2009 Apr; 58(4):800-2. PubMed ID: 19336690
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects.
    Saadi H; Nagelkerke N; Carruthers SG; Benedict S; Abdulkhalek S; Reed R; Lukic M; Nicholls MG
    Diabetes Res Clin Pract; 2008 Jun; 80(3):392-8. PubMed ID: 18282631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The WNT signalling pathway and diabetes mellitus.
    Jin T
    Diabetologia; 2008 Oct; 51(10):1771-80. PubMed ID: 18696049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet specific Wnt activation in human type II diabetes.
    Lee SH; Demeterco C; Geron I; Abrahamsson A; Levine F; Itkin-Ansari P
    Exp Diabetes Res; 2008; 2008():728763. PubMed ID: 19165345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population.
    Chang YC; Chang TJ; Jiang YD; Kuo SS; Lee KC; Chiu KC; Chuang LM
    Diabetes; 2007 Oct; 56(10):2631-7. PubMed ID: 17579206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells.
    da Silva Xavier G; Loder MK; McDonald A; Tarasov AI; Carzaniga R; Kronenberger K; Barg S; Rutter GA
    Diabetes; 2009 Apr; 58(4):894-905. PubMed ID: 19168596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No major contribution of TCF7L2 sequence variants to maturity onset of diabetes of the young (MODY) or neonatal diabetes mellitus in French white subjects.
    Cauchi S; Vaxillaire M; Choquet H; Durand E; Duval A; Polak M; Froguel P
    Diabetologia; 2007 Jan; 50(1):214-6. PubMed ID: 17093940
    [No Abstract]   [Full Text] [Related]  

  • 19. The transcription factor 7-like 2 gene and increased risk of type 2 diabetes: an update.
    Lyssenko V
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):385-92. PubMed ID: 18541996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population.
    Loos RJ; Franks PW; Francis RW; Barroso I; Gribble FM; Savage DB; Ong KK; O'Rahilly S; Wareham NJ
    Diabetes; 2007 Jul; 56(7):1943-7. PubMed ID: 17416797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.